Kexing Biopharm Co., Ltd. (Stock Code: 688136.SH) recently announced that the Investigational New Drug Application ...

Stock analysts at Leerink Partnrs lowered their FY2025 earnings estimates for MoonLake Immunotherapeutics in a report issued on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now ...

Designing Life with AI" is a cross-disciplinary MAKE project in which EPFL students get a chance to explore the research ...

For decades, lab-made antibodies have been used to support patients fighting specific diseases. These treatments have become ...

The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

Feb. 11, 2025 — A recent study by two biological science researchers found that a pathogen for bird pink eye remained viable on bird feeders in winter months much ... 'Junk' RNA Segments Play ...

Initial data from the Phase 1 trial expected in 2025 SAN FRANCISCO, CALIFORNIA, Jan. 27, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno ...

Feb. 5, 2025 — A new study has found that certain bacteria were associated with better memory and attention, while others were linked to an increased risk of Alzheimer's ... Scientists Reveal ...